arginyl-glycyl-aspartic acid has been researched along with osteoprotegerin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DM; Arai, F; Miyamoto, T; Ohneda, O; Suda, T; Takagi, K | 1 |
| Choi, SJ; Kurihara, N; Oba, Y; Roodman, GD | 1 |
| Ashley, JW; Cody, JJ; Douglas, JT; Feng, X; Lyons, GR; Meleth, S; Rivera, AA; Siegal, GP; Wang, M; Yang, SW | 1 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and osteoprotegerin
| Article | Year |
|---|---|
An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Carrier Proteins; Cell Adhesion; Cell Culture Techniques; Cell Differentiation; Cell Division; Cells, Cultured; Culture Media; Female; Giant Cells; Glycoproteins; Hematopoietic Stem Cells; Integrin alphaV; Integrin beta3; Leucine Zippers; Macrophage Colony-Stimulating Factor; Macrophages; Membrane Glycoproteins; Methylcellulose; Mice; Mice, Inbred C57BL; Models, Biological; Oligopeptides; Osteoclasts; Osteoprotegerin; Plastics; Platelet Membrane Glycoproteins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2000 |
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Calcitriol; Carrier Proteins; Cysteine Endopeptidases; Female; Glycoproteins; Humans; Membrane Glycoproteins; Mice; Mutagenesis; Oligopeptides; Osteoclasts; Osteoprotegerin; Peptides; Plant Proteins; Protein Structure, Tertiary; RANK Ligand; Rats; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2001 |
Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model.
Topics: Adenoviridae; Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Humans; Immunoglobulin G; Luciferases; Male; Mice; Oligopeptides; Oncolytic Virotherapy; Osteoclasts; Osteoprotegerin; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; X-Ray Microtomography | 2013 |